Phase II, randomised, double‐blind, placebo‐controlled trial of methylphenidate for reduction of fatigue levels in patients with prostate cancer receiving LHRH‐agonist therapy

By  

BJU INTERNATIONAL, Vol. 1464-4096, Iss. 5, 2015-11 ,pp. : 744-752

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effects of melatonin on physical fatigue and other symptoms in patients with advanced cancer receiving palliative care: A double‐blind placebo‐controlled crossover trial

By  

CANCER, Vol. 121, Iss. 20, 2015-10 ,pp. : 3727-3736

John Wiley & Sons Inc

Access to resources Recommend Favorite

Calcitriol does not prevent bone loss in patients with asthma receiving corticosteroid therapy: a double-blind placebo-controlled trial

By McDonald C.   Zebaze R.   Seeman E.  

Osteoporosis International, Vol. 17, Iss. 10, 2006-10 ,pp. : 1546-1551

Springer Publishing Company

Access to resources Recommend Favorite

Efficacy of combination therapy with probiotics and mosapride in patients with IBS without diarrhea: a randomized, double‐blind, placebo‐controlled, multicenter, phase II trial

By  

NEUROGASTROENTEROLOGY & MOTILITY (ELECTRONIC), Vol. 27, Iss. 5, 2015-05 ,pp. : 705-716

John Wiley & Sons Inc

Access to resources Recommend Favorite

A double-blind, double-dummy, randomized, placebo-controlled trial to evaluate the effect of statin therapy on triglyceride levels in Mexican hypertriglyceridemic patients

By Talavera Juan-Osvaldo   Martinez Gustavo   Cervantes Jose-Luis   Marin Javier-Aguila   Rodriguez-Briones Ignacio   Gonzalez Jose-Gerardo   Ocampo Rodolfo   Sanchez-Mijangos Hector   Bernal-Rosales Laura P.   Polanco Ana  

Current Medical Research and Opinion, Vol. 29, Iss. 4, 2013-04 ,pp. : 379-386

Informa Healthcare

Access to resources Recommend Favorite